David Mountcastle - Jun 28, 2022 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role
EVP & Chief Financial Officer
Signature
/s/ Thomas Bartrum, as attorney-in fact
Stock symbol
PRVA
Transactions as of
Jun 28, 2022
Transactions value $
-$896
Form type
4
Date filed
6/30/2022, 02:35 PM
Previous filing
Apr 5, 2022
Next filing
Jul 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVA Common Stock, $0.01 par value per share Options Exercise $64.00 +32 +0.04% $2.00* 81.1K Jun 28, 2022 Direct
transaction PRVA Common Stock, $0.01 par value per share Sale -$960 -32 -0.04% $30.00 81.1K Jun 28, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVA Stock Option (Right to Purchase) Options Exercise $0 -32 -0.09% $0.00 37.1K Jun 28, 2022 Common Stock 32 $2.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021.
F2 Reflects stock options to purchase shares of common stock of the Issuer under the Plan. 28,242 of the stock options are fully vested and exercisable. 6,438 of the stock options will vest on October 29, 2022, and 2,493 of the stock options will vest on December 4, 2022.